{"id":1186,"date":"2021-03-01T07:52:25","date_gmt":"2021-03-01T12:52:25","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=1186"},"modified":"2026-04-14T10:35:12","modified_gmt":"2026-04-14T14:35:12","slug":"high-specificity-aptamers-for-sars-cov-2","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/","title":{"rendered":"High-Specificity Aptamers for SARS-CoV-2"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"1186\" class=\"elementor elementor-1186\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cb16a8d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"cb16a8d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3b6b456\" data-id=\"3b6b456\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9a348dd elementor-widget elementor-widget-text-editor\" data-id=\"9a348dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>NeoVentures has successfully developed aptamers for both the spike protein and the nucleoprotein of SARS-CoV-2 (COVID-19). Spike protein aptamers were developed against a recombinant S1 protein from the Wuhan strain expressed in HEK293 cells in order to maintain appropriate glycosylation, counter selection was performed against SARS-CoV (SARS) S1 protein. A high level of specificity for SARS-CoV-2 was obtained.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-febfc33 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"febfc33\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b4ca4da\" data-id=\"b4ca4da\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a49f73d elementor-widget elementor-widget-image\" data-id=\"a49f73d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"504\" src=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-768x504.png\" class=\"attachment-medium_large size-medium_large wp-image-1179\" alt=\"Aptamers for Covid-19\" srcset=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-768x504.png 768w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-300x197.png 300w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-1024x672.png 1024w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-1536x1008.png 1536w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment-2048x1344.png 2048w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-158a600 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"158a600\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0b5f593\" data-id=\"0b5f593\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e62fddf elementor-widget elementor-widget-text-editor\" data-id=\"e62fddf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Aptamers with low nM kD values for each protein were identified. NeoVentures has entered into several confidential partnerships for the development of COVID-19 diagnostics based on these aptamers. We have found that the nucleoprotein aptamers are providing us with the necessary sensitivity (1E3 to 1E5 virus particles\/mL) for commercial antigen detection. We are prepared to license aptamers for both protein targets to third parties. Please contact us if you would like more information <a href=\"https:\/\/neoaptamers.com\/fr\/contact-our-team\/\">here<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>NeoVentures has successfully developed aptamers for both the spike protein and the nucleoprotein of SARS-CoV-2 (COVID-19). Spike protein aptamers were developed against a recombinant S1 protein from the Wuhan strain expressed in HEK293 cells in order to maintain appropriate glycosylation, counter selection was performed against SARS-CoV (SARS) S1 protein. A high level of specificity for&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">High-Specificity Aptamers for SARS-CoV-2<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1179,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-1186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>High-Specificity Aptamers for SARS-CoV-2<\/title>\n<meta name=\"description\" content=\"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"High-Specificity Aptamers for SARS-CoV-2\" \/>\n<meta property=\"og:description\" content=\"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T12:52:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T14:35:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2121\" \/>\n\t<meta property=\"og:image:height\" content=\"1392\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"partyinfrance\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"partyinfrance\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/\"},\"author\":{\"name\":\"partyinfrance\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/34934951075d3d931c9216ed7f568fe6\"},\"headline\":\"High-Specificity Aptamers for SARS-CoV-2\",\"datePublished\":\"2021-03-01T12:52:25+00:00\",\"dateModified\":\"2026-04-14T14:35:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/\"},\"wordCount\":137,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/annment.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/\",\"name\":\"High-Specificity Aptamers for SARS-CoV-2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/annment.png\",\"datePublished\":\"2021-03-01T12:52:25+00:00\",\"dateModified\":\"2026-04-14T14:35:12+00:00\",\"description\":\"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/annment.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/annment.png\",\"width\":2121,\"height\":1392,\"caption\":\"Aptamers for Covid-19\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/high-specificity-aptamers-for-sars-cov-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"High-Specificity Aptamers for SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/34934951075d3d931c9216ed7f568fe6\",\"name\":\"partyinfrance\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"caption\":\"partyinfrance\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"High-Specificity Aptamers for SARS-CoV-2","description":"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/","og_locale":"fr_FR","og_type":"article","og_title":"High-Specificity Aptamers for SARS-CoV-2","og_description":"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.","og_url":"https:\/\/neoaptamers.com\/fr\/high-specificity-aptamers-for-sars-cov-2\/","og_site_name":"neoaptamers","article_published_time":"2021-03-01T12:52:25+00:00","article_modified_time":"2026-04-14T14:35:12+00:00","og_image":[{"width":2121,"height":1392,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png","type":"image\/png"}],"author":"partyinfrance","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"partyinfrance","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/"},"author":{"name":"partyinfrance","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/34934951075d3d931c9216ed7f568fe6"},"headline":"High-Specificity Aptamers for SARS-CoV-2","datePublished":"2021-03-01T12:52:25+00:00","dateModified":"2026-04-14T14:35:12+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/"},"wordCount":137,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/","url":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/","name":"High-Specificity Aptamers for SARS-CoV-2","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png","datePublished":"2021-03-01T12:52:25+00:00","dateModified":"2026-04-14T14:35:12+00:00","description":"NeoVentures has developed high-specificity aptamers for the SARS-CoV-2 Wuhan strain. Contact us to learn about licensing opportunities.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/03\/annment.png","width":2121,"height":1392,"caption":"Aptamers for Covid-19"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/high-specificity-aptamers-for-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"High-Specificity Aptamers for SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/34934951075d3d931c9216ed7f568fe6","name":"partyinfrance","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","caption":"partyinfrance"}}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/1186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=1186"}],"version-history":[{"count":12,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/1186\/revisions"}],"predecessor-version":[{"id":6582,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/1186\/revisions\/6582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/1179"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=1186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=1186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=1186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}